Employment Agreement effective July 1, 2010 with Jorge Rodriguez

“Agreement” means this Agreement and all schedules and amendments hereto.

“Approved Holder” means any person or group of persons acting in concert which as of the date of this Agreement hold, directly or indirectly, a sufficient number of the outstanding Voting Shares to affect materially the control of the Company.

“Base Salary” has the meaning attributed to it in Section 3.1(a) of this Agreement.

“Board” means the Board of Directors of the Company.

“Company” has the meaning attributed to it on Page 1 of this Agreement.

“Change of Control Event” means the occurrence of any one of the events set out in sections 1.1(f)(i) to 1.1(f)(iv) below:

an acquisition, directly or indirectly, of Voting Shares, whether through one transaction or a number of transactions, by any person or group of persons acting in concert (other than an Approved Holder) the result of which is that such person or group of persons hold, directly or indirectly, at least forty (40%) percent of the Voting Shares;

the consummation of a merger, amalgamation or consolidation of the Company with or into another entity or any other corporate reorganization, if more than 50% of the combined voting power of the continuing or surviving entity’s securities outstanding immediately after the transaction are owned by persons who were not stockholders of the Company or an Approved Holder immediately prior to such merger, amalgamation, consolidation or reorganization;

the consummation by an entity, person or group (other than the Company, a wholly owned subsidiary of the Company, or an Approved Holder) of a tender offer, an exchange offer, a take-over bid or any other offer or bid for more than 40% of the issued and outstanding common shares of the Company; or

consummation of a sale, transfer or disposition by the Company of all or substantially all of the assets of the Company.

In the case of the occurrence of any of the events set forth in this section 1.1(f), a Change of Control Event shall be deemed to occur immediately prior to the occurrence of any such events. An event shall not constitute a Change of Control Event if it is a merger with a parent or subsidiary, or its sole purpose is to change the jurisdiction of the Company’s organization or to create a holding company, partnership or trust that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such event or by the persons who held Striker’s securities immediately before such event. Additionally, a Change of Control Event will not be deemed to have occurred, with respect to the Executive, if the Executive is part of a purchasing group that consummates the Change of Control Event.

“Common Shares” means the common shares, without par value, of Striker.

“Competing Business” shall have the meaning attributed to it in Section 5.3, below.

“Confidential Information” means information, whether or not originated by the Executive, that relates to the business or affairs of the Company, its affiliates, clients or suppliers and is confidential or proprietary to, about or created by the Company, its affiliates, clients, or suppliers. Confidential Information includes, but is not limited to, the following types of confidential information and other proprietary information of a similar nature (whether or not reduced to writing or designated or marked as confidential):

work product resulting from or related to work or projects performed for or to be performed for the Company or its affiliates, including but not limited to, the methods, processes, procedures, analysis, techniques and audits used in connection therewith;

computer software of any type or form and in any stage of actual or anticipated development including, by way of example and not in limitation, programs and program modules, routines and subroutines, procedures, algorithms, design concepts, design specifications (design notes, annotations, documentation, flowcharts, coding sheets, and the like), source code, object code and load modules, programming, program patches and system designs;

information relating to Developments prior to any public disclosure thereof including, by way of example and not in limitation, the nature of the Developments, production data, technical and engineering data, test data and test results, the status and details of research and development of products and services, and information regarding acquiring, protecting, enforcing and licensing proprietary rights (including patents, copyrights and trade secrets);

internal Company personnel and financial information, vendor names and other vendor information, purchasing and internal cost information, internal services and operational manuals, and the manner and method of conducting the Company’s business;

marketing and development plans, price and cost data, price and fee amounts, pricing and billing policies, quoting procedures, marketing techniques and methods of obtaining business, forecasts and forecast assumptions and volumes, current and prospective client lists, and future plans and potential strategies of the Company that have been or are being discussed; and

all information that becomes known to the Executive as a result of employment that the Executive, acting reasonably, believes is Confidential Information or that the Company takes measures to protect.

Confidential Information does not include:

the general skills and experience gained during the Executive’s employment or engagement with the Company that the Executive could reasonably have been expected to acquire in similar employment or engagements with other companies;

information publicly known without breach of this Agreement or similar agreements; or

information, the disclosure of which is required to be made by any law, regulation or governmental authority (to the extent of the requirement), provided that before disclosure is made, notice of the requirement (and the extent of the requirement) is provided to the Company (to the extent reasonably possible in the circumstances), and the Company is afforded an opportunity to dispute the requirement.

“Date of Termination” means the date of termination of this Agreement pursuant to its terms.

“Developments” means all discoveries, inventions, designs, works of authorship, improvements and ideas (whether or not patentable or copyrightable) and legally recognized proprietary rights (including, but not limited to, patents, copyrights, trademarks, topographies, know-how and trade secrets), and all records and copies of records relating to the foregoing, that:

result or derive from the Executive’s employment or from the Executive’s knowledge or use of Confidential Information;

are conceived or made by the Executive (individually or in collaboration with others) during the term of and related to the Executive’s employment by the Company;

result from or derive from the use or application of the resources of the Company or its affiliates; or

relate to the business operations of the Company or to actual or demonstrably anticipated research and development by the Company or its affiliates.

“Directors” means the Directors of the Company, and “Director” means any one of them.

“Effective Date” means July 1, 2010.

“Employee Benefits” shall have the meaning attributed in Section 4.1, below.

“Good Reason” means the occurrence of any of the following events without the express written consent of the Executive:

any material reduction or diminution (except temporarily during any period of physical or mental incapacity or disability of the Executive or one resulting from the request of the Executive) in the Executive’s title(s), status, position(s), authority, duties or responsibilities with the Company; or

a material breach by the Company of this Agreement.

the Company’s re-location of the Executive’s place of work to a distance not less than 50 miles by usual highways from the Executive’s agreed place of work at the effective date of this agreement, without mutual agreement of the Executive and the Company.

“Indemnification Amounts” has the meaning attributed in Section 7.1, below.

“Initial Term” means the period of time beginning on the Effective Date and ending on the second anniversary of the Effective Date.

“Just Cause” includes, but is not limited to:

the Executive’s failure to properly discharge his lawful duties, or any material breach or non-observance by the Executive of any material provision of this Agreement;

the Executive’s conviction for any crime respecting the property of the Company, or which calls into question the Executive’s personal honesty;

any breach by the Executive of his obligations under the Company’s code of conduct or any policies or procedures adopted by the Company from time to time, and disseminated to employees in accordance with the Company’s normal practice, provided that such conduct would amount to just cause as a matter of common law;

any breach by the Executive of the fiduciary duties normally owed by a Chief Commercial Officer of a corporation including the duty to avoid conflicts of interest, and to act honestly and in good faith with a view to the best interests of the Company;

any other material breach of this Agreement by the Executive; or

just cause as that term is defined by the common law applicable in New Jersey.

“Performance Bonus” has the meaning attributed in Section 3.1(a), below.

“Performance Bonus Criteria” has the meaning attributed in Section 3.1(a), below.

“Renewal Term” means any period of time after expiration of the Initial Term during which the employment of the Executive pursuant to this Agreement continues, if the parties to this Agreement have agreed to the renewal in writing.

“Striker” means Striker Energy Corp., a Nevada corporation and, as of the Effective Date, the sole stockholder of the Company and its surviving corporate entities following a corporate action or actions.

“Termination Notice Period” is the period of six (6) months plus two (2) months per year of employment of the Executive up to a maximum of twelve (12) months during which the terms of this Agreement shall remain in effect following notice of termination being given by the Executive or the Company pursuant to Section 6.3 below.

“Voting Shares” means voting shares of the Company or Striker.

“Year” means any year during the term of this Agreement whether occurring during the Initial Term or, if applicable, any Renewal Terms.

report to the Chief Executive Officer and take direction from the Chief Executive Officer ;

attend meetings of the Board as required by the Chief Executive Officer or the Board, make a report at such meetings describing the status of the Company and addressing such other matters as may be required by the Chief Executive Officer or the Board;

ensure that all contracts and similar arrangements of the Company shall be approved and signed in accordance with the signing authorities authorized by the Board from time to time.

Base Salary. The Company will pay the Executive the sum of $150,000 per annum effective July 1, 2010 (the “Base Salary”), with payments made on the 15th and last day of each month or as agreed to in the normal payroll processing that the Company shall adopt.

Performance Bonus. The Executive shall be eligible to receive an annual bonus at the end of each Year (the “Performance Bonus”) initially targeted to be 50% of Base Salary (the “Target Bonus”). Both the decision to pay a Performance Bonus and the amount of a Performance Bonus, shall be at the discretion of the Board, acting reasonably and in accordance with the Performance Bonus criteria established in Striker’s Compensation Plan to be proposed and submitted to the Board for approval (the “Performance Bonus Criteria”). The bonus is payable in cash, in Striker equity, or as a combination of both. In the case of the Performance Bonus paid as a combination of cash and equity, the cash portion shall be not less than 50% of the total value of the Performance Bonus.

Equity Compensation – Stock Options. The Executive shall be eligible to receive an annual stock option award at the end of each Year (the “Option Award”). Both the decision to make an Option Award and the amount and specifics of the Option Award shall be at the discretion of the Board, acting reasonably and in accordance with the Option Award criteria to be established as part of Striker’s Compensation Plan and in compliance with all applicable laws and the rules of any quotation system or stock exchange. It is intended that such options will be options of Striker.

the Executive will cease to participate in the Employee Benefits and will not be entitled to any further benefits thereunder, except for medical and dental benefits which may be continued at his own expense for a period of six (6) months after the Date of Termination; and

the Executive will be solely responsible for obtaining personal benefit plans to replace any or all Employee Benefits, including, without limitation, health insurance, dental insurance and long term disability insurance.

All Confidential Information, whether developed by the Executive while employed by the Company or by others employed or engaged by or associated with the Company or its affiliates or clients, is the exclusive and confidential property of the Company or its affiliates or clients, as the case may be, and will at all times be regarded, treated and protected as such, as provided in this Agreement.

As a consequence of the acquisition of Confidential Information or arising from his position as Chief Commercial Officer, the Executive will occupy a position of trust and confidence with respect to the affairs and business of the Company and its affiliates and clients. In view of the foregoing, it is reasonable and necessary for the Executive to make the following covenants regarding the Executive’s conduct during and subsequent to the Executive’s employment by the Company.

At all times during and subsequent to the Executive’s employment with the Company, the Executive will not disclose Confidential Information to any person (other than as necessary in carrying out the Executive’s duties on behalf of the Company) without first obtaining the Company’s consent, and the Executive will take all reasonable precautions to prevent inadvertent disclosure of any Confidential Information.

At all times during and subsequent to the Executive’s employment with the Company, the Executive will not use, copy, transfer or destroy any Confidential Information (other than as necessary in carrying out the Executive’s duties on behalf of the Company) without first obtaining the Company’s consent and the Executive will take all reasonable precautions to prevent inadvertent use, copying, transfer or destruction of any Confidential Information. This prohibition includes, but is not limited to, licensing or otherwise exploiting, directly or indirectly, any products or services that embody or are derived from Confidential Information or exercising judgment or performing analysis based upon knowledge of Confidential Information.

Within ten (10) business days after the termination of the Executive’s employment for any reason, the Executive will promptly deliver to the Company all property of or belonging to or administered by the Company including without limitation all Confidential Information that is embodied in any form, whether in hard copy or on electronic media, and that is within the Executive’s possession or under the Executive’s control.

All Developments will be the exclusive property of the Company and the Company will have sole discretion to deal with Developments. The Executive agrees that no intellectual property rights in the Developments are or will be retained by him. For greater certainty, all work done during the term of employment by the Executive for the Company or its affiliates is the sole property of the Company or its affiliates, as the case may be, as the first author for copyright purposes and in respect of which all copyright will vest in the Company or the relevant affiliate, as the case may be. In consideration of the benefits to be received by the Executive under the terms of this Agreement, the Executive hereby irrevocably sells, assigns and transfers and agrees in the future to sell, assign and transfer all right, title and interest in and to the Developments and intellectual property rights therein including, without limitation, all patents, copyright, industrial design, circuit topography and trademarks, and any goodwill associated therewith to the Company and the Executive will hold all the benefits of the rights, title and interest mentioned above in trust for the Company prior to the assignment to the Company.

The Executive will do all further things that may be reasonably necessary or desirable in order to give full effect to the foregoing. If the Executive’s cooperation is required in order for the Company to obtain or enforce legal protection of the Developments following the termination of the Executive’s employment, the Executive will provide that cooperation so long as the Company pays to the Executive reasonable compensation for the Executive’s time at a rate to be agreed between the Executive and the Company.

contact companies or persons who were investors in, or who purchased or agreed to purchase products or services of, the Company or Striker within a two year period before the Date of Termination, on behalf of a Competing Business or

solicit any of the Company’s or Striker’s employees or consultants to resign or work for any other business or

himself work for a Competing Business unless Termination was pursuant to section 6.3.

any Stock Options granted to the Executive which have not vested shall vest immediately and be immediately exercisable subject to the terms of Striker’s stock option plan and any applicable Stock Option Agreement;

the Company shall promptly pay and provide the Executive (or in the event of the Executive’s death, the Executive’s estate):

any unpaid Base Salary and any outstanding and accrued regular and special vacation pay through the Date of Termination; and

reimbursement for any unreimbursed expenses incurred through to the Date of Termination; and

the Company shall pay to the Executive (or in the event of the Executive’s death, the Executive’s estate) the continuing payroll payments referred to in section 6.3.

The Executive may elect to terminate his employment with the Company for Good Reason at any time within thirty (30) days after the date the Executive has given written notice to the Company of the alleged “Good Reason” and provided that the Company has failed to cure such event or situation within 30 days of receiving said notice In such event, the Company will continue to pay the Executive in accordance with the Company’s normal payroll procedures and the Executive will continue to perform his duties under the Agreement during the applicable Termination Notice Period, or the Company, at its discretion, may pay a lump sum to the Executive equal to the salary payable during the remainder of the Termination Notice Period (the “Lump Sum Payment”). Additionally, the Executive may be entitled to a pro-rata Performance Bonus based upon an objective evaluation of the Executive’s achievement of goals in accordance with section 3.1(b) up to the date of Termination, calculated by multiplying the Target Bonus by the fraction which represents the number of months elapsed from July 1 of the fiscal year in question through the Date of Termination divided by twelve (12). For clarity, the Date of Termination will be the earlier of the last day of the Termination Notice Period or the date on which the Company, at its discretion, pays the Lump Sum Payment.

The Company may elect to terminate the Executive’s employment at any time for other than Just Cause following the Termination Notice Period by delivering to the Executive written notice of termination in advance of the Termination Notice Period. In such event, the Company will continue to pay the Executive in accordance with the Company’s normal payroll procedures during the applicable Termination Notice Period, and the Executive will continue to perform his duties under the Agreement during the applicable Termination Notice Period, or the Company, at its discretion, may pay a lump sum to the Executive equal to the salary payable during the remainder of the Termination Notice Period. Additionally, the Executive may be entitled to a pro-rata Performance Bonus based upon an objective evaluation of the Executive’s achievement of goals in accordance with section 3.1(b) up to the date of Termination, calculated by multiplying the Target Bonus by the fraction which represents the number of months elapsed from July 1 of the fiscal year in question through the Date of Termination divided by twelve (12). For clarity, the Date of Termination will be the earlier of the last day of the Termination Notice Period or the date on which the Company, at its discretion, pays the Lump Sum Payment.

If the Executive is terminated pursuant to this section 6.3 the Stock Options granted to the Executive will continue to vest for the number of months of the applicable Termination Notice Period, notwithstanding any election by the Company to pay the Lump Sum Payment to the Executive and will be exercisable subject to the terms of the applicable stock option plan.

If the Executive is terminated pursuant to this section 6.7, the Stock Options granted to the Executive which have not vested shall vest immediately and be immediately exercisable subject to the terms of the applicable stock option plan.

Budgetary responsibility as per Operating Plan. Responsible for allocation of overall budget to projects, preparation of budget phasings, monitoring of performance against budget, forecasting.

Co-ordination of marketing projects, working across the company, with customers and with external agencies.

Purchasing authority as per Company mandated limits.

Development of PediatRx strategic marketing plan (including 3 year revenue and expenditure plans), one year brand-specific marketing plan and support for field development of one year district and sales business plans. Specifically, this will apply to existing PediatRx brands, as well as possible licensing targets. Evaluating and refining brand and portfolio positioning and assumptions will be key.

Developing marketing effectiveness tools and metrics and identifying and executing best practice from within and outside the pharmaceutical industry.

Delivery of Operating Plan revenue and expenditure by implementation of marketing plans. Input to monthly report and monitoring brand performance v. key metrics.

Identifying actions to be taken to rectify actual and potential deviations from the Operating Plan.

Development of differential customer offerings tailored to the specific needs of customer groups (healthcare professionals, patients, parents).

Input in to product and business development opportunities.

Ensure that Sales Leadership, District Managers, Distribution/Reimbursement, Marketers and Representatives have a clear understanding of, and involvement in, defining the portfolio and key brand strategy and implementation requirements; preparation and execution of POAs.

Regular liaison with the lead District Managers assigned to launch teams on issues affecting brand launch strategy and implementation and taking the necessary action.

Regular liaison with senior management, Business Development, Regulatory Affairs, Finance, MIS and other groups to ensure steady and high quality information flow and to identify and develop opportunities.

Regular liaison with Field Advisory Board members and relevant external customers.

Provide developmental support for cross-functional team, both as a team and as individuals.

Decision Making

Without day-to-day reference to manager, but with input as necessary :

Resolution of conflicting brand priorities and deadlines.

Volume and sales forecasting and reforecasting, phasing.

Approval of promotional material at copy and artwork stages.

Planning and approval of expenditure up to limits in Operating/Marketing Plan.

Briefing and other contact with external agencies.

With reference to manager :

Definition of brand strategies and activities.

Written proposals for presentation to board.

Planning for product introductions and discontinuations.

Major changes to brand strategy or marketing plan.

Personal development and career planning.

People Management